Drug
pilocarpine hydrochloride
pilocarpine hydrochloride is a pharmaceutical drug with 5 clinical trials. Historical success rate of 75.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_3
4
80%
Ph phase_1
1
20%
Phase Distribution
1
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 3Large-scale testing
4(80.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(1)
Other(1)
Detailed Status
Completed3
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (20.0%)
Phase 34 (80.0%)
Trials by Status
terminated120%
unknown120%
completed360%
Recent Activity
0 active trials
Showing 5 of 5
unknownphase_1
Comparison of a Compound With Pilocarpine and Brimonidine to Improve Near Vision in Healthy Presbyopic Patients
NCT05001243
completedphase_3
Oral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens Syndrome
NCT04470479
terminatedphase_3
Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids
NCT00003686
completedphase_3
Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer
NCT00343382
completedphase_3
Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
NCT00003139
Clinical Trials (5)
Showing 5 of 5 trials
NCT05001243Phase 1
Comparison of a Compound With Pilocarpine and Brimonidine to Improve Near Vision in Healthy Presbyopic Patients
NCT04470479Phase 3
Oral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens Syndrome
NCT00003686Phase 3
Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids
NCT00343382Phase 3
Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer
NCT00003139Phase 3
Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5